Literature DB >> 23600840

Increased frequency of skin-infiltrating FoxP3+ regulatory T cells as a diagnostic indicator of severe atopic dermatitis from cutaneous T cell lymphoma.

T Hanafusa1, S Matsui, H Murota, M Tani, K Igawa, I Katayama.   

Abstract

Differential diagnosis of cutaneous T cell lymphoma (CTCL) and severe atopic dermatitis (AD) is often difficult because of the similarity in their skin manifestations. However, such differentiation is extremely important because of the differences in remedy and prognosis. The aim of this study was to investigate new, helpful diagnostic aids for distinguishing CTCL from AD. The frequency of forkhead box protein 3(+) (FoxP3(+)) regulatory T cells (T(regs)) in cutaneous lesions was evaluated among the three populations. Serum-soluble interleukin-2 receptor (sIL-2R), immunoglobulin (Ig)E-radioimmunosorbent test, lactate dehydrogenase (LDH) and blood eosinophil count were measured in 11 CTCL patients (including three CTCL patients misdiagnosed previously with intractable AD), 10 adult AD patients and nine psoriasis patients. The frequency of T(regs) was increased significantly in cutaneous lesions of AD compared with those of CTCL. Serum IgE and LDH levels were also elevated significantly in AD compared with CTCL, whereas there were no significant differences in serum sIL-2R levels between CTCL and AD. In the three CTCL patients who were misdiagnosed with intractable AD, IgE and LDH levels were lower than in AD patients, whereas serum sIL-2R levels were as high as in AD patients and higher than in the other eight CTCL patients. The higher frequency of T(regs) in the cutaneous lesions of patients with AD than in those with CTCL and higher serum IgE and LDH levels in patients with AD than in those with CTCL might be helpful reference values for the differential diagnosis of these two diseases.
© 2013 British Society for Immunology.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23600840      PMCID: PMC3646451          DOI: 10.1111/cei.12073

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  10 in total

Review 1.  Japanese guideline for atopic dermatitis.

Authors:  Ichiro Katayama; Yoichi Kohno; Kazuo Akiyama; Zenro Ikezawa; Naomi Kondo; Kunihiko Tamaki; Osamu Kouro
Journal:  Allergol Int       Date:  2011-03       Impact factor: 5.836

2.  Serum soluble CD26 levels: diagnostic efficiency for atopic dermatitis, cutaneous T-cell lymphoma and psoriasis in combination with serum thymus and activation-regulated chemokine levels.

Authors:  T Miyagaki; M Sugaya; H Suga; S Morimura; M Kamata; H Ohmatsu; H Fujita; Y Asano; Y Tada; T Kadono; S Sato
Journal:  J Eur Acad Dermatol Venereol       Date:  2011-11-14       Impact factor: 6.166

3.  Frequency, function and CLA expression of CD4+CD25+FOXP3+ regulatory T cells in bullous pemphigoid.

Authors:  Anne Rensing-Ehl; Barbara Gaus; Leena Bruckner-Tuderman; Stefan F Martin
Journal:  Exp Dermatol       Date:  2007-01       Impact factor: 3.960

4.  Atopic dermatitis-like pre-Sézary syndrome: role of immunosuppression.

Authors:  Małgorzata Sokołowska-Wojdyło; Wioletta Barańska-Rybak; Agnieszka Cegielska; Magdalena Trzeciak; Hanna Lugowska-Umer; Robert Gniadecki
Journal:  Acta Derm Venereol       Date:  2011-09       Impact factor: 4.437

5.  Use of serum soluble interleukin-2 receptor levels to monitor the progression of cutaneous T-cell lymphoma.

Authors:  E C Vonderheid; Q Zhang; S R Lessin; M Polansky; J T Abrams; R D Bigler; M A Wasik
Journal:  J Am Acad Dermatol       Date:  1998-02       Impact factor: 11.527

6.  Diminished regulatory T cells in cutaneous lesions of thymoma-associated multi-organ autoimmunity: a newly described paraneoplastic autoimmune disorder with fatal clinical course.

Authors:  T Hanafusa; H Azukizawa; S Kitaba; H Murota; N Umegaki; M Terao; S Sano; T Nakagiri; M Okumura; I Katayama
Journal:  Clin Exp Immunol       Date:  2011-11       Impact factor: 4.330

Review 7.  Erythrodermic cutaneous T-cell lymphoma: how to differentiate this rare disease from atopic dermatitis.

Authors:  Tomomitsu Miyagaki; Makoto Sugaya
Journal:  J Dermatol Sci       Date:  2011-08-05       Impact factor: 4.563

Review 8.  Cutaneous T cell lymphoma: update on treatment.

Authors:  Uwe Wollina
Journal:  Int J Dermatol       Date:  2012-09       Impact factor: 2.736

9.  Proliferation cell nuclear antigen and soluble interleukin 2 receptor levels in cutaneous T cell lymphoma: correlation with advanced clinical diseases.

Authors:  C Neish; M Charlry; B Jegasothy; M Tharp; J S Deng
Journal:  J Dermatol Sci       Date:  1994-08       Impact factor: 4.563

10.  Analysis of FOXP3 protein expression in human CD4+CD25+ regulatory T cells at the single-cell level.

Authors:  Giovanna Roncador; Philip J Brown; Lorena Maestre; Sophie Hue; Jorge L Martínez-Torrecuadrada; Khoon-Lin Ling; Sarah Pratap; Christy Toms; Bridget C Fox; Vincenzo Cerundolo; Fiona Powrie; Alison H Banham
Journal:  Eur J Immunol       Date:  2005-06       Impact factor: 5.532

  10 in total
  3 in total

1.  Therapeutic reduction of cell-mediated immunosuppression in mycosis fungoides and Sézary syndrome.

Authors:  Larisa J Geskin; Oleg E Akilov; Soonyou Kwon; Michael Schowalter; Simon Watkins; Theresa L Whiteside; Lisa H Butterfield; Louis D Falo
Journal:  Cancer Immunol Immunother       Date:  2017-12-04       Impact factor: 6.968

2.  Comparison of molecular signatures from multiple skin diseases identifies mechanisms of immunopathogenesis.

Authors:  Megan S Inkeles; Philip O Scumpia; William R Swindell; David Lopez; Rosane M B Teles; Thomas G Graeber; Stephan Meller; Bernhard Homey; James T Elder; Michel Gilliet; Robert L Modlin; Matteo Pellegrini
Journal:  J Invest Dermatol       Date:  2014-08-11       Impact factor: 8.551

Review 3.  The role of regulatory T cells and genes involved in their differentiation in pathogenesis of selected inflammatory and neoplastic skin diseases. Part II: The Treg role in skin diseases pathogenesis.

Authors:  Bogusław Nedoszytko; Magdalena Lange; Małgorzata Sokołowska-Wojdyło; Joanna Renke; Piotr Trzonkowski; Michał Sobjanek; Aneta Szczerkowska-Dobosz; Marek Niedoszytko; Aleksandra Górska; Jan Romantowski; Justyna Czarny; Jarosław Skokowski; Leszek Kalinowski; Roman Nowicki
Journal:  Postepy Dermatol Alergol       Date:  2017-10-31       Impact factor: 1.837

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.